GlobeNewswire

CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28/04/2026
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led Clinical Study in Pachyonychia Congenita Study Will be Led [...]
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 28 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
28/04/2026
EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adopted Dividend of Euro 4.00 per share, with option for payment in shares Paris, France (28 April 2026 – 6:00 pm [...]
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026
Assemblée générale 2026 d’EssilorLuxottica Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 4,00 € par action, avec possibilité de choisir un versement en actions Paris, France (28 [...]
Clariane announces the success of its offering of €230 million of additional senior notes
28/04/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane [...]
Clariane annonce le succès de son offre de 230 millions d’euros d’obligations senior additionnelles
28/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
Axe Compute to Present at the Market Movers Investor Summit and the D. Boral Capital 2026 Global Conference
28/04/2026
CEO Chris Miglino to deliver the Company's presentation at the Market Movers Investor Summit on Tuesday, May 5, 2026, at 9:20 a.m. ET — covering Axe Compute's enterprise GPU compute platform, infrastructure scale across [...]
NBPure Launches Exclusive MagO7 60-Count at Walmart, Expanding Access to Its Best-Selling Gut Cleanse
28/04/2026
PHOENIX, April 28, 2026 (GLOBE NEWSWIRE) -- NBPure, a trusted leader in gut-first wellness for more than 28 years, today announced the launch of its flagship MagO7 cleanse at Walmart stores, a significant step in [...]
Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026
28/04/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first quarter of 2026 in the morning on Tuesday, 5 May 2026. Later on the same day, the company will host a presentation for investors and [...]
The Aesthetic Show Celebrates 19 Years of Innovation, Education, and Excellence in Aesthetic Medicine — Announces Expanded 2026 Event in Las Vegas, June 25 - 28
28/04/2026
LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- The Aesthetic Show (TAS), one of the most respected and dynamic events in aesthetic medicine, proudly announces its 19th annual gathering this June 25th - 28th, marking [...]
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
28/04/2026
LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- via IBN — BioAdaptives, Inc. (OTC: BDPT) today announced the official launch of MyndSystem™ and website. MyndSystem™ was originally developed for professional fighters. We [...]
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026
28/04/2026
Oslo, Norway, 28 April 2026 Vistin Pharma ASA (OSE: VISTN); please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 20 May 2026 at 13:00 CEST. It will not be possible with physical [...]
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
28/04/2026
Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it believes to be the largest catalog of regRNAs ever compiled, uncovering thousands of previously undiscovered regRNAs in human [...]
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
28/04/2026
Buntanetap improved cognition in pTau217-positive early AD patients The drug reduced neurotoxic proteins as well as biomarkers of neuroinflammation and neurodegeneration Buntanetap was safe and well-tolerated, including [...]
Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology
28/04/2026
BURLINGAME, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately-held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent [...]
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
28/04/2026
Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per batch that is among the lowest in the industry Initial translational data [...]
Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies
28/04/2026
Kestrel has entered into a warrant agreement with AbbVie with an exclusive option for AbbVie to acquire the Company based on defined development milestones WATERTOWN, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Kestrel [...]
Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time
28/04/2026
New AI capabilities create a feedback loop where analyst input and automated analysis continuously improve threat detection and response BOSTON, April 28, 2026 (GLOBE NEWSWIRE) -- Cynet, the unified, AI-powered [...]
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
28/04/2026
- Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for individuals living with Duchenne muscular dystrophy - CHARLESTOWN, Mass., [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum